SEC Form 4 · accession 0001179110-15-011953
OSIRIS THERAPEUTICS, INC. · OSIR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alla Danilkovitch
Officer — Chief Scientific Officer
Period of report
Aug 10, 2015
Accepted (ET)
Aug 11, 2015 · 6:32 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001360886
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 10, 2015 | M | 5,000 | $0.40 | A | 10,375 | D | |
| Common StockF1 | Aug 10, 2015 | S | 2,425 | $18.22 | D | 7,950 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1 | $0.40 | Aug 10, 2015 | M | 5,000 | D | Dec 1, 2006 | Dec 1, 2015 | Common Stock | 5,000 | 93,000 | D |
Explanation of responses
- F1Represents the same-day sale exercise of non-qualified stock options granted under our Amended and Restated 1994 Stock Incentive Plan, whereby 5,000 options were exercised and 2,425 shares were concurrently retired to pay the exercise cost and taxes on the related gain, resulting in the net issuance of 2,575 shares of common stock.